HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Outcomes of CD19 chimeric antigen receptor T cell followed by haploidentical hematopoietic stem-cell transplantation in relapsed/refractory B-cell acute lymphoblastic leukemia with IKZF1 deletion.

AuthorsFang Ni, Elaine Tan Su Yin, Linghui Zhou, Houli Zhao, Yi Luo, Jimin Shi, Yongxian Hu, He Huang
JournalBone marrow transplantation (Bone Marrow Transplant) Vol. 57 Issue 2 Pg. 326-328 (02 2022) ISSN: 1476-5365 [Electronic] England
PMID35067672 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD19
  • IKZF1 protein, human
  • Receptors, Antigen, T-Cell
  • Receptors, Chimeric Antigen
  • Ikaros Transcription Factor
Topics
  • Antigens, CD19
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Ikaros Transcription Factor
  • Immunotherapy, Adoptive
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Receptors, Antigen, T-Cell (genetics)
  • Receptors, Chimeric Antigen
  • T-Lymphocytes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: